ImmunoGenesis
Industry
- Biotechnology
- Large Molecule
- Pharmaceuticals
See more in Biomedtracker
Latest on ImmunoGenesis
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck Obtains Global Rights To Hansoh’
Scrip
• By Mandy Jackson
Venture capital investment in the biopharmaceutical industry continues to be massive in terms of both the number of companies raising funds and the size of funding rounds despite the ongoing economic